Express News | Guardant Health Launches Enhanced Guardant360 Test On Guardant Infinity Platform; New Test Covers 10 Times More Genes And Quantifies Tumor Burden With 10 Times Higher Sensitivity; Medicare And Major Private Payers Cover Test For Comprehensive Genomic...
Guardant Health Introduces Major Smart Liquid Biopsy Upgrade to Market-Leading Guardant360 Test, Further Extending Its Best-in-Class Performance
Cathie Wood-Led Ark Invest Sells $8M In Tesla Shares Despite Bullish Autonomy Forecast
Guardant Health Appoints Oncology Expert to Board of Directors
Express News | DR. Manuel Hidalgo Medina Joins Guardant Health Board of Directors
Guardant Health Is Maintained at Buy by B of A Securities
BofA Securities Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $40
Express News | Guardant Health Inc : BofA Global Research Raises Price Objective to $40 From $28
Express News | Guardant Health Inc : Bernstein Raises Target Price to $37 From $33
Assessing Guardant Health: Insights From 7 Financial Analysts
Express News | Goldman Sachs Maintains Buy on Guardant Health, Raises Price Target to $32
Express News | Guardant Health Inc : TD Cowen Raises Target Price to $41 From $37
Express News | Guardant Health Inc : TD Cowen Raises Target Price to $42 From $37
Is Guardant Health (NASDAQ:GH) Using Too Much Debt?
Top Premarket Gainers
Express News | Guardant Health Shares up 3.1% Premarket After Guggenheim Raises to Buy From Neutral
Guggenheim Initiates Guardant Health(GH.US) With Buy Rating, Announces Target Price $36
Express News | Guardant Health Inc : Guggenheim Raises to Buy From Neutral
American Cancer Society Projects Over 2 Million New Cases in 2024: Biotech Innovations Respond
Guardant Health (GH) Now Trades Above Golden Cross: Time to Buy?